Gene Therapy for Type 1 Diabetes Moves a Step Closer to Reality

Overview

Journal Diabetes

Specialty Endocrinology

Date 2013 Apr 25

PMID 23613564

Authors

Timothy OBrien

Affiliations

Soon will be listed here.

References

Maguire A, High K, Auricchio A, Wright J, Pierce E, Testa F . Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial. Lancet. 2009; 374(9701):1597-605. PMC: 4492302. DOI: 10.1016/S0140-6736(09)61836-5. View

Norgaard K, Scaramuzza A, Bratina N, Lalic N, Jarosz-Chobot P, Kocsis G . Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study. Diabetes Technol Ther. 2013; 15(4):273-80. PMC: 3696941. DOI: 10.1089/dia.2012.0288. View

Bonifacio E . Immunotherapy in type 1 diabetes: a shorter but more winding road?. Diabetes. 2012; 61(9):2214-5. PMC: 3425430. DOI: 10.2337/db12-0648. View

Pickup J . Insulin-pump therapy for type 1 diabetes mellitus. N Engl J Med. 2012; 366(17):1616-24. DOI: 10.1056/NEJMct1113948. View

. Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. Diabet Med. 2006; 23(8):857-66. DOI: 10.1111/j.1464-5491.2006.01925.x. View

Callejas D, Mann C, Ayuso E, Lage R, Grifoll I, Roca C . Treatment of diabetes and long-term survival after insulin and glucokinase gene therapy. Diabetes. 2013; 62(5):1718-29. PMC: 3636629. DOI: 10.2337/db12-1113. View

Nathwani A, Tuddenham E, Rangarajan S, Rosales C, McIntosh J, Linch D . Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med. 2011; 365(25):2357-65. PMC: 3265081. DOI: 10.1056/NEJMoa1108046. View

Rask-Madsen C, King G . Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab. 2013; 17(1):20-33. PMC: 3546345. DOI: 10.1016/j.cmet.2012.11.012. View

Godfrey K, Mathew B, Bulman J, Shah O, Clement S, Gallicano G . Stem cell-based treatments for Type 1 diabetes mellitus: bone marrow, embryonic, hepatic, pancreatic and induced pluripotent stem cells. Diabet Med. 2011; 29(1):14-23. DOI: 10.1111/j.1464-5491.2011.03433.x. View

10.

McCall M, Shapiro A . Update on islet transplantation. Cold Spring Harb Perspect Med. 2012; 2(7):a007823. PMC: 3385934. DOI: 10.1101/cshperspect.a007823. View

11.

Agrawal P, Welsh J, Kannard B, Askari S, Yang Q, Kaufman F . Usage and effectiveness of the low glucose suspend feature of the Medtronic Paradigm Veo insulin pump. J Diabetes Sci Technol. 2011; 5(5):1137-41. PMC: 3208869. DOI: 10.1177/193229681100500514. View

12.

Breton M, Farret A, Bruttomesso D, Anderson S, Magni L, Patek S . Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia. Diabetes. 2012; 61(9):2230-7. PMC: 3425406. DOI: 10.2337/db11-1445. View

13.

Nathan D, Genuth S, Lachin J, Cleary P, Crofford O, Davis M . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14):977-86. DOI: 10.1056/NEJM199309303291401. View

14.

Buchlis G, Podsakoff G, Radu A, Hawk S, Flake A, Mingozzi F . Factor IX expression in skeletal muscle of a severe hemophilia B patient 10 years after AAV-mediated gene transfer. Blood. 2012; 119(13):3038-41. PMC: 3321866. DOI: 10.1182/blood-2011-09-382317. View

15.

van der Windt D, Bottino R, Kumar G, Wijkstrom M, Hara H, Ezzelarab M . Clinical islet xenotransplantation: how close are we?. Diabetes. 2012; 61(12):3046-55. PMC: 3501885. DOI: 10.2337/db12-0033. View

16.

Mingozzi F, High K . Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat Rev Genet. 2011; 12(5):341-55. DOI: 10.1038/nrg2988. View

17.

Dominguez-Bendala J, Lanzoni G, Inverardi L, Ricordi C . Concise review: mesenchymal stem cells for diabetes. Stem Cells Transl Med. 2012; 1(1):59-63. PMC: 3727686. DOI: 10.5966/sctm.2011-0017. View

18.

Shaw J, Sicree R, Zimmet P . Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2009; 87(1):4-14. DOI: 10.1016/j.diabres.2009.10.007. View

19.

Stanekzai J, Isenovic E, Mousa S . Treatment options for diabetes: potential role of stem cells. Diabetes Res Clin Pract. 2012; 98(3):361-8. DOI: 10.1016/j.diabres.2012.09.010. View

20.

Ly T, Nicholas J, Retterath A, Davis E, Jones T . Analysis of glucose responses to automated insulin suspension with sensor-augmented pump therapy. Diabetes Care. 2012; 35(7):1462-5. PMC: 3379608. DOI: 10.2337/dc12-0052. View